Search research articles
Contact Us
Filters
Showing results (141-150 of 167) with videos related to
Page
of 17
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 10, 2015
Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome
Iskra Pusic, Jaebok Choi, Mark A Fiala, et al.
Leukemia & Lymphoma
|
May 14, 2013
The characteristics and outcomes of patients with multiple myeloma dual refractory or intolerant to bortezomib and lenalidomide in the era of carfilzomib and pomalidomide
Tzu-Fei Wang, Rohan Ahluwalia, Mark A Fiala, et al.
Journal of the American Heart Association
|
June 2, 2016
Restoration of Mitochondrial Cardiolipin Attenuates Cardiac Damage in Swine Renovascular Hypertension
Alfonso Eirin, Behzad Ebrahimi, Soon Hyo Kwon, et al.
Gynecologic Oncology
|
March 2, 2021
A deficit-accumulation frailty index predicts survival outcomes in patients with gynecologic malignancy
Mary M Mullen, Tyler R McKinnish, Mark A Fiala, et al.
Leukemia Research
|
August 10, 2016
Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation
Armin Ghobadi, Jaebok Choi, Mark A Fiala, et al.
Blood Advances
|
October 7, 2025
Ablation of CD38 in Multiple Myeloma Cells Leads to an Aggressive Phenotype in a Mouse Xenograft Model
Michael Riley Dyer, Alexander Zheleznyak, Erin N Teubner, et al.
Leukemia
|
September 16, 2022
Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myeloma
Michael Slade, Thomas G Martin, Nitya Nathwani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 23, 2020
VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival
Francesca Fontana, Michael J Scott, John S Allen, et al.
Transplantation and Cellular Therapy
|
August 19, 2023
Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation
Ziheng Xu, Jaebok Choi, Matthew Cooper, et al.
Gut
|
October 24, 2009
Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens
J G Fox, Y Feng, E J Theve, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 167) with videos related to
Sort By:
Page
of 17
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 10, 2015
Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome
Iskra Pusic, Jaebok Choi, Mark A Fiala, et al.
Leukemia & Lymphoma
|
May 14, 2013
The characteristics and outcomes of patients with multiple myeloma dual refractory or intolerant to bortezomib and lenalidomide in the era of carfilzomib and pomalidomide
Tzu-Fei Wang, Rohan Ahluwalia, Mark A Fiala, et al.
Journal of the American Heart Association
|
June 2, 2016
Restoration of Mitochondrial Cardiolipin Attenuates Cardiac Damage in Swine Renovascular Hypertension
Alfonso Eirin, Behzad Ebrahimi, Soon Hyo Kwon, et al.
Gynecologic Oncology
|
March 2, 2021
A deficit-accumulation frailty index predicts survival outcomes in patients with gynecologic malignancy
Mary M Mullen, Tyler R McKinnish, Mark A Fiala, et al.
Leukemia Research
|
August 10, 2016
Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation
Armin Ghobadi, Jaebok Choi, Mark A Fiala, et al.
Blood Advances
|
October 7, 2025
Ablation of CD38 in Multiple Myeloma Cells Leads to an Aggressive Phenotype in a Mouse Xenograft Model
Michael Riley Dyer, Alexander Zheleznyak, Erin N Teubner, et al.
Leukemia
|
September 16, 2022
Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myeloma
Michael Slade, Thomas G Martin, Nitya Nathwani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 23, 2020
VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival
Francesca Fontana, Michael J Scott, John S Allen, et al.
Transplantation and Cellular Therapy
|
August 19, 2023
Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation
Ziheng Xu, Jaebok Choi, Matthew Cooper, et al.
Gut
|
October 24, 2009
Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens
J G Fox, Y Feng, E J Theve, et al.
Page
of 17